Jose A Lorente
Overview
Explore the profile of Jose A Lorente including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
153
Citations
2832
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Keough-Delgado E, Lopez-Rodriguez L, de Olaiz B, Bertomeu-Garcia A, Penuelas O, Jimenez-Fernandez M, et al.
J Appl Physiol (1985)
. 2021 Apr;
130(6):1736-1742.
PMID: 33830811
Ventilator-induced diaphragm dysfunction (VIDD) is increasingly recognized as an important side-effect of invasive ventilation in critically ill patients and is associated with poor outcomes. Whether patients with VIDD benefit from...
22.
Simon I, Perales S, Casado-Medina L, Rodriguez-Martinez A, Garrido-Navas M, Puche-Sanz I, et al.
Cancers (Basel)
. 2021 Apr;
13(6).
PMID: 33807106
Androgen deprivation therapy (ADT) and novel hormonal agents (NHAs) (Abiraterone and Enzalutamide) are the goal standard for metastatic prostate cancer (PCa) treatment. Although ADT is initially effective, a subsequent castration...
23.
Grinan-Lison C, Blaya-Canovas J, Lopez-Tejada A, Avalos-Moreno M, Navarro-Ocon A, Cara F, et al.
Antioxidants (Basel)
. 2021 Feb;
10(2).
PMID: 33572626
Breast cancer is the most frequent cancer and the leading cause of cancer death in women. Oxidative stress and the generation of reactive oxygen species (ROS) have been related to...
24.
Morales-Cano D, Barreira B, Navarro B, Callejo M, Mondejar-Parreno G, Esquivel-Ruiz S, et al.
Antioxidants (Basel)
. 2021 Jan;
10(2).
PMID: 33494520
Current approved therapies for pulmonary hypertension (PH) aim to restore the balance between endothelial mediators in the pulmonary circulation. These drugs may exert vasodilator effects on poorly oxygenated vessels. This...
25.
Herrero R, Sanchez G, Asensio I, Lopez E, Ferruelo A, Vaquero J, et al.
Intensive Care Med Exp
. 2020 Dec;
8(Suppl 1):48.
PMID: 33336286
Patients with liver diseases are at high risk for the development of acute respiratory distress syndrome (ARDS). The liver is an important organ that regulates a complex network of mediators...
26.
Lopez Cuenca S, Oteiza L, Lazaro Martin N, Ibarz M, Irazabal M, Artigas A, et al.
Rev Esp Geriatr Gerontol
. 2020 Dec;
56(1):5-10.
PMID: 33309421
Background And Objectives: Currently, the patient's baseline situation is a more important prognostic factor than age. The purpose of this study is to estimate the prognostic value of the ISAR...
27.
Ortega F, Regiart M, Rodriguez-Martinez A, de Miguel-Perez D, Serrano M, Lorente J, et al.
Anal Chem
. 2020 Dec;
93(2):1143-1153.
PMID: 33301317
This study is focused on identifying novel epithelial markers in circulating extracellular vesicles (EVs) through the development of a dual sandwich-type electrochemical paper-based immunosensor for Claudin 7 and CD81 determination,...
28.
Serrano M, Lorente J
Cancers (Basel)
. 2020 Nov;
12(11).
PMID: 33158185
From the medical and scientific point of view, we are witnessing important changes in the way we approach diseases, and consequently in the way we manage patients [...].
29.
Avalos-Moreno M, Lopez-Tejada A, Blaya-Canovas J, Cara-Lupianez F, Gonzalez-Gonzalez A, Lorente J, et al.
J Pers Med
. 2020 Nov;
10(4).
PMID: 33138097
Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer which presents a high rate of relapse, metastasis, and mortality. Nowadays, the absence of approved specific targeted therapies...
30.
Serrano M, Garrido-Navas M, Diaz Mochon J, Cristofanilli M, Gil-Bazo I, Pauwels P, et al.
Cancer Discov
. 2020 Oct;
10(11):1635-1644.
PMID: 33037026
Despite major therapeutic progress, most advanced solid tumors are still incurable. Cancer interception is the active way to combat cancer onset, and development of this approach within high-risk populations seems...